Growth Metrics

Teladoc Health (TDOC) Gains from Investment Securities (2016 - 2026)

Teladoc Health's Gains from Investment Securities history spans 14 years, with the latest figure at -$42000.0 for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities fell 112.8% to -$42000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$6.8 million, a 163.4% decrease, with the full-year FY2025 number at -$6.4 million, down 171.53% from a year prior.
  • Gains from Investment Securities hit -$42000.0 in Q1 2026 for Teladoc Health, up from -$6.3 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for TDOC hit a ceiling of $8.9 million in Q4 2024 and a floor of -$12.0 million in Q4 2023.
  • Historically, Gains from Investment Securities has averaged $104392.3 across 5 years, with a median of $198880.5 in 2022.
  • The widest YoY moves for Gains from Investment Securities: up 7829.93% in 2023, down 201.72% in 2023.
  • Tracing TDOC's Gains from Investment Securities over 5 years: stood at $69761.0 in 2022, then crashed by 17314.49% to -$12.0 million in 2023, then surged by 174.49% to $8.9 million in 2024, then plummeted by 170.86% to -$6.3 million in 2025, then skyrocketed by 99.34% to -$42000.0 in 2026.
  • Business Quant data shows Gains from Investment Securities for TDOC at -$42000.0 in Q1 2026, -$6.3 million in Q4 2025, and -$388000.0 in Q2 2025.